Cov

Logo GlobeNewswire
SciencePress Release2023-03-29 12:00:00
BOTHELL, Wash., March 29, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) reports financial results for the 12 months ended December 31, 2022,...

Logo Daily Mail
FootballBy Will Griffee2023-03-29 07:54:47
Colby Covington is talking up International Fight Week for a showdown with Leon Edwards this summer. 'Chaos' wants to share the event with Jon Jones, who...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-29 20:45:00
CorEnergy Infrastructure Trust, Inc. CORR CORRPrA))) ("CorEnergy" or the "Company") announced today that it has filed its Form 10-K for the year ended...

Logo CBS News
HealthBy Dr Céline Gounder2023-03-29 13:45:56
Although COVID-19 cases and hospitalizations have decreased, long COVID remains a constant presence in the lives of many Americans. Long COVID has affected...

Logo PR Newswire
EntertainmentPress Release2023-03-29 18:00:00
TORONTO, March 29, 2023 /PRNewswire/ - Corus Entertainment Inc. ("Corus" or the "Company") (TSX: CJR.B) will release its second quarter fiscal 2023 results...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-03-29 17:01:10
Cormedix CRMD is set to give its latest quarterly earnings report on Thursday, 2023-03-30. Here's what investors need to know before the announcement....

Logo PR Newswire
Company Receives MOD Designation for Mixed-Use 154,000 Square foot Property, Paving the Way for Increased Value Creation ST. JAMES, N.Y., March 29, 2023...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-29 15:45:00
Oragenics, Inc. OGEN ("Oragenics" or the "Company"), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces that Kim...

Logo PR Newswire
TechnologyPress Release2023-03-29 13:00:00
More than 30 companies are now partnering with Innovaccer and leveraging its industry-leading data platform to accelerate innovation and transformation in...

Logo U.S. News & World Report
PoliticsBy Cecelia Smith Schoenwalder2023-03-29 18:55:16
The World Health Organization on Wednesday said that it is monitoring XBB.1.16, an omicron subvariant that has been documented mostly in India. We're...

Logo EIN Presswire
Honorable Dr. Rafael Marrero con su diploma de Coronel Tarjeta de identificación de Coronel

Logo Benzinga
Business / FinanceBy Business Wire2023-03-23 11:44:00
Coya Therapeutics, Inc. COYA ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance...

Logo EIN Presswire
HealthPress Release2023-03-29 08:00:00
LONDON, UK, March 29, 2023/ EINPresswire.com / -- In a global display of appreciation, thousands of people are recognizing social media influencers who used...

Logo GlobeNewswire
SciencePress Release2023-03-29 20:00:00
Received regulatory approval for the ongoing First-In-Human Phase 1 trial to demonstrate clinical safety and antibody response in humans for DYAI-100...

Logo PR Newswire
A Compact Lightweight Body Designed to Give Creators the Ultimate Video and Content Creation Tool SAN DIEGO, March 29, 2023 /PRNewswire/ -- Sony Electronics...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-29 16:07:00
Platform allows users to rapidly, safely and effectively harness powerful Large Language Model technologies for social listening, media monitoring and other...

Logo Nasdaq
TechnologyBy Market Insite2023-03-29 13:00:00
Clementina Torres, Chief Operational Officer of Depsito Central de Valores, has been involved in the central securities depository space for over a decade....

Logo BBC
HealthBy Https://Www Facebook Com/Bbcnews2023-03-30 05:16:35
Islanders are being asked to share their stories from the coronavirus lockdowns to form a historical resource Thursday marks three years since the island...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-29 16:39:00
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of Aetna...

Logo Nasdaq
Business / FinanceBy Fintel2023-03-29 12:25:42
On March 28, 2023, UBS upgraded their outlook for Coherus Biosciences (NASDAQ:CHRS) from Neutral to Buy. Analyst Price Forecast Suggests 172.08% Upside As of...